179 related articles for article (PubMed ID: 33610748)
1. Identification of a new class of HBV capsid assembly modulator.
Kuduk SD; Stoops B; Alexander R; Lam AM; Espiritu C; Vogel R; Lau V; Klumpp K; Flores OA; Hartman GD
Bioorg Med Chem Lett; 2021 May; 39():127848. PubMed ID: 33610748
[TBL] [Abstract][Full Text] [Related]
2. SAR studies in the sulfonyl carboxamide class of HBV capsid assembly modulators.
Kuduk SD; Lam AM; Espiritu C; Vogel R; Lau V; Klumpp K; Flores OA; Hartman GD
Bioorg Med Chem Lett; 2019 Aug; 29(16):2405-2409. PubMed ID: 31227344
[TBL] [Abstract][Full Text] [Related]
3. Oxadiazepinone HBV capsid assembly modulators.
Kuduk SD; Stoops B; Lam AM; Espiritu C; Vogel R; Lau V; Klumpp K; Flores OA; Hartman GD
Bioorg Med Chem Lett; 2021 Nov; 52():128353. PubMed ID: 34492302
[TBL] [Abstract][Full Text] [Related]
4. Design, diversity-oriented synthesis and biological evaluation of novel heterocycle derivatives as non-nucleoside HBV capsid protein inhibitors.
Jia H; Yu J; Du X; Cherukupalli S; Zhan P; Liu X
Eur J Med Chem; 2020 Sep; 202():112495. PubMed ID: 32712535
[TBL] [Abstract][Full Text] [Related]
5. Preclinical Characterization of NVR 3-778, a First-in-Class Capsid Assembly Modulator against Hepatitis B Virus.
Lam AM; Espiritu C; Vogel R; Ren S; Lau V; Kelly M; Kuduk SD; Hartman GD; Flores OA; Klumpp K
Antimicrob Agents Chemother; 2019 Jan; 63(1):. PubMed ID: 30373799
[TBL] [Abstract][Full Text] [Related]
6. Structure-Based Discovery of
Yang Y; Yan Y; Yin J; Hu J; Cai X; Hu J; Xia J; Wang K; Tang N; Huang L
Viruses; 2022 Feb; 14(2):. PubMed ID: 35215939
[TBL] [Abstract][Full Text] [Related]
7. Discovery of novel HBV capsid assembly modulators by structure-based virtual screening and bioassays.
Wang Y; Wang Z; Liu J; Wang Y; Wu R; Sheng R; Hou T
Bioorg Med Chem; 2021 Apr; 36():116096. PubMed ID: 33721800
[TBL] [Abstract][Full Text] [Related]
8. Identification of (6S)-cyclopropyl-6,7-dihydropyrazolo[1,5-a]pyrazine-5(4H)-carboxamines as new HBV capsid assembly modulators.
Lv K; Wu S; Tao Z; Wang A; Xu S; Yang L; Gao Q; Wang A; Qin X; Jiang B; Wu W; Jia X; Li Y; Jiang J; Liu M
Eur J Med Chem; 2022 Jan; 228():113974. PubMed ID: 34772528
[TBL] [Abstract][Full Text] [Related]
9. Design and synthesis of aminothiazole based Hepatitis B Virus (HBV) capsid inhibitors.
Pan T; Ding Y; Wu L; Liang L; He X; Li Q; Bai C; Zhang H
Eur J Med Chem; 2019 Mar; 166():480-501. PubMed ID: 30739828
[TBL] [Abstract][Full Text] [Related]
10. Antiviral Properties and Mechanism of Action Studies of the Hepatitis B Virus Capsid Assembly Modulator JNJ-56136379.
Berke JM; Dehertogh P; Vergauwen K; Mostmans W; Vandyck K; Raboisson P; Pauwels F
Antimicrob Agents Chemother; 2020 Apr; 64(5):. PubMed ID: 32094138
[TBL] [Abstract][Full Text] [Related]
11. Design, synthesis, and structure-activity relationship of a bicyclic HBV capsid assembly modulator chemotype leading to the identification of clinical candidate AB-506.
Cole AG; Kultgen SG; Mani N; Quintero JG; Yi Fan K; Ardzinski A; Stever K; Dorsey BD; Phelps JR; Lee ACH; Thi EP; Chiu T; Tang S; Horanyi PS; Mayclin SJ; Harasym TO; Sofia MJ
Bioorg Med Chem Lett; 2023 Oct; 94():129456. PubMed ID: 37633618
[TBL] [Abstract][Full Text] [Related]
12. Current Progress in the Development of Hepatitis B Virus Capsid Assembly Modulators: Chemical Structure, Mode-of-Action and Efficacy.
Kim H; Ko C; Lee JY; Kim M
Molecules; 2021 Dec; 26(24):. PubMed ID: 34946502
[TBL] [Abstract][Full Text] [Related]
13. Design, synthesis and anti-HBV activity of NVR3-778 derivatives.
Lv K; Wu S; Li W; Geng Y; Wu M; Zhou J; Li Y; Gao Q; Liu M
Bioorg Chem; 2020 Jan; 94():103363. PubMed ID: 31669092
[TBL] [Abstract][Full Text] [Related]
14. Discovery of (1
Wang C; Pei Y; Wang L; Li S; Jiang C; Tan X; Dong Y; Xiang Y; Ma Y; Liu G
J Med Chem; 2020 Jun; 63(11):6066-6089. PubMed ID: 32421339
[TBL] [Abstract][Full Text] [Related]
15. Diazepinone HBV capsid assembly modulators.
Kuduk SD; DeRatt LG; Stoops B; Shaffer P; Lam AM; Espiritu C; Vogel R; Lau V; Flores OA; Hartman GD
Bioorg Med Chem Lett; 2022 Sep; 72():128823. PubMed ID: 35644301
[TBL] [Abstract][Full Text] [Related]
16. 4-Oxooctahydroquinoline-1(2H)-carboxamides as hepatitis B virus (HBV) capsid core protein assembly modulators.
Hwang N; Ban H; Wu S; McGuire K; Hernandez E; Chen J; Zhao Q; Suresh M; Blass B; Viswanathan U; Kulp J; Chang J; Clement J; Menne S; Guo JT; Du Y
Bioorg Med Chem Lett; 2022 Feb; 58():128518. PubMed ID: 34979256
[TBL] [Abstract][Full Text] [Related]
17. Hepatitis B Virus Capsid Assembly Modulators, but Not Nucleoside Analogs, Inhibit the Production of Extracellular Pregenomic RNA and Spliced RNA Variants.
Lam AM; Ren S; Espiritu C; Kelly M; Lau V; Zheng L; Hartman GD; Flores OA; Klumpp K
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28559265
[TBL] [Abstract][Full Text] [Related]
18. Novel Potent Capsid Assembly Modulators Regulate Multiple Steps of the Hepatitis B Virus Life Cycle.
Lahlali T; Berke JM; Vergauwen K; Foca A; Vandyck K; Pauwels F; Zoulim F; Durantel D
Antimicrob Agents Chemother; 2018 Oct; 62(10):. PubMed ID: 30012770
[TBL] [Abstract][Full Text] [Related]
19. Capsid Assembly Modulators Have a Dual Mechanism of Action in Primary Human Hepatocytes Infected with Hepatitis B Virus.
Berke JM; Dehertogh P; Vergauwen K; Van Damme E; Mostmans W; Vandyck K; Pauwels F
Antimicrob Agents Chemother; 2017 Aug; 61(8):. PubMed ID: 28584155
[TBL] [Abstract][Full Text] [Related]
20. Pyrimidotriazine derivatives as selective inhibitors of HBV capsid assembly.
Toyama M; Sakakibara N; Takeda M; Okamoto M; Watashi K; Wakita T; Sugiyama M; Mizokami M; Ikeda M; Baba M
Virus Res; 2019 Oct; 271():197677. PubMed ID: 31376401
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
